Last $18.86 USD
Change Today +0.44 / 2.39%
Volume 761.5K
DEPO On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James A. Schoeneck

Chief Executive Officer, President and Director, DepoMed Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 2 different organizations across 5 different industries.

See Board Relationships
56$2,414,730
As of Fiscal Year 2013

Background*

Mr. James A. Schoeneck, also known as Jim, has been the Chief Executive Officer and President of DepoMed Inc., since April 18, 2014. Mr. Schoeneck serves as a Strategic Advisor to Kreido Laboratories. He served as the Chief Executive Officer of BrainCells Inc. since October 2005. Mr. Schoeneck served as Chief Executive Officer of ActivX Biosciences Inc., from November 2003 to December 2004. Mr. Schoeneck served as President and Chief Executive Officer of Prometheus ...

Read Full Background

Corporate Headquarters*

7999 Gateway Boulevard
Newark, California 94560

United States

Phone: 510-744-8000
Fax: 510-744-8001

Board Members Memberships*

Former Chief Executive Officer and Director
2005-N/A
Former Chief Executive Officer and Director
2007-Present
Chief Executive Officer, President and Director
2010-Present
Non-Employee Director

Education*

BS
Jacksonville State University

Other Affiliations*

Annual Compensation*

Salary$590,625
Total Annual Compensation$590,625

Stock Options*

Restricted Stock Awards$710,850
All Other Compensation$14,074
Exercisable Options482,354
Exercisable Options Value$1,494,973
Unexercisable Options379,646
Unexercisable Options Value$1,219,607
Total Value of Options$2,714,580
Total Number of Options862,000

Total Compensation*

Total Annual Cash Compensation$1,029,699
Total Short Term Compensation$590,625
Other Long Term Compensation$724,924
Total Calculated Compensation$2,414,730
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DEPO:US $18.86 USD +0.44

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
$1.0M
Timothy P. Walbert Chairman, Chief Executive Officer and President
Horizon Pharma plc
$589.2K
Richard Herring Chief Executive Officer and Director
APN Outdoor Group Limited
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEPOMED INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.